Given that NUAK1 can inhibit the activity of GSK3β by promoting the phosphorylation of GSK3β at serine9, we first examined the effects of NUAK1 on β-catenin expression in HCC cells. The gene discussed is GSK3B; the disease is hepatocellular carcinoma.